Keyphrases
Beta-blocker Therapy
100%
Beta-blockers
16%
Bisoprolol
83%
Cardiopulmonary Interactions
100%
Cardiovascular Disease
16%
Carvedilol
100%
Ex-smokers
16%
Exercise Heart Rate
16%
Forced Expiratory Volume in 1 Second (FEV1)
33%
Forced Vital Capacity
16%
Formoterol
16%
ICS-LABA
50%
Inhaled Corticosteroids
16%
Inhaled Therapy
100%
Long-acting beta-agonists
16%
Long-acting muscarinic Antagonist
16%
Lung Compliance
16%
Moderate to Severe
16%
Patient-completed
16%
Pulmonary Function
33%
Resting Heart Rate
16%
Severe COPD
16%
Tiotropium
16%
Tolerability
16%
Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Beta Adrenergic Receptor Stimulating Agent
16%
Bisoprolol
83%
Cardiovascular Disease
16%
Carvedilol
100%
Chronic Obstructive Pulmonary Disease
100%
Forced Expiratory Volume
33%
Forced Vital Capacity
16%
Formoterol
16%
Lung Compliance
16%
Lung Function
33%
Muscarinic Antagonist
16%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Adrenergic Receptor Blocking Agent
100%
Beta Adrenergic Receptor Stimulating Agent
16%
Bisoprolol
83%
Cardiovascular Disease
16%
Carvedilol
100%
Chronic Obstructive Lung Disease
100%
Formoterol
16%
Muscarinic Receptor Blocking Agent
16%
Tolerability
16%